# Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/three-arm-phase-ii-trial-comparing-camrelizumab-plus-chemotherapy-versus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yang Yang,Li Zhu,Yan Cheng,Zhichao Liu,Xiaoyue Cai,Jinchen Shao,Ming Zhang,Jun Liu,Yifeng Sun,Yin Li,Jun Yi,Bentong Yu,Hongjing Jiang,Hezhong Chen,Hong Yang,Lijie Tan,Zhigang Li |
| Citations | 36 |
| DOI | 10.1186/s12885-022-09573-6 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://link.springer.com/content/pdf/10.1186/s12885-022-09573-6.pdf |
| OpenAlex ID | https://openalex.org/W4229046570 |
| PMID | 35524205 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Jinchen Shao](https://scholariq.org/researchers/jinchen-shao/)

## Paper journal

- [BMC Cancer](https://scholariq.org/journals/bmc-cancer/)

## Paper primary topic

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)

## Paper topics

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.